BioVaxys Technology Corp.
BIOV
CNSX
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -27.28% | 10.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.28% | 7.43% | |||
| Operating Income | 27.28% | -7.43% | |||
| Income Before Tax | 28.50% | -23.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.50% | -23.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.50% | -23.01% | |||
| EBIT | 27.28% | -7.43% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 29.28% | -11.85% | |||
| Normalized Basic EPS | 28.28% | 5.26% | |||
| EPS Diluted | 29.28% | -11.85% | |||
| Normalized Diluted EPS | 28.28% | 5.26% | |||
| Average Basic Shares Outstanding | 1.14% | 9.92% | |||
| Average Diluted Shares Outstanding | 1.14% | 9.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||